Sun Pharmaceutical advanced as much as 2.17 percent on Thursday as the pharma major got a go-ahead from the US Food and Drug Administration (USFDA) for its ophthalmic drug.
For more information on commodity tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
Sign up here with your email